InsiderSignal.AI

InsiderSignal.ai

SI - Shoulder Innovations, Inc.

Insider Purchase by Ball Robert Joseph (CEO, Exec COB)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

4 days ago, Ball Robert Joseph, serving as CEO, Exec COB at Shoulder Innovations, Inc. (SI), purchased 2,200 shares at $15.18 per share, for a total transaction value of $33,392.00. Following this transaction, Ball Robert Joseph now holds 278,866 shares of SI.

This purchase represents a 1.00% increase in Ball Robert Joseph's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Friday, March 13, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, March 17, 2026, 4 days after the trade was made.

Shoulder Innovations, Inc. operates in the NONE sector, specifically within the NONE industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Ball Robert Joseph

Ball Robert Joseph

CEO, Exec COB

Robert Joseph Ball is the Executive Chairman and CEO of Shoulder Innovations, Inc. (NYSE: SI), a specialized orthopedic device company focused on shoulder replacement technology[[1]](https://www.medsider.com/interviews/rob-ball-shoulder-innovations)[[2]](https://exa.ai/websets/directory/shoulder-innovations-executives). With over two decades of experience in medical device development, Ball has established himself as a key innovator in orthopedics, holding more than 30 issued or pending patents[[1]](https://www.medsider.com/interviews/rob-ball-shoulder-innovations)[[2]](https://exa.ai/websets/directory/shoulder-innovations-executives). He earned both his Bachelor's and Master's degrees in Mechanical Engineering from Kettering University, with specialized focus on automotive engineering and mechanical design[[2]](https://exa.ai/websets/directory/shoulder-innovations-executives). His career spans roles at major medical device companies including Johnson & Johnson's DePuy division, where he gained foundational expertise in product development and regulatory processes[[1]](https://www.medsider.com/interviews/rob-ball-shoulder-innovations). Ball's most significant professional achievement came during his tenure at Tornier (now Wright Medical), where he served as Global Vice President of Research and Development for approximately eight years and drove substantial organic revenue growth from $40-50 million to $300 million[[1]](https://www.medsider.com/interviews/rob-ball-shoulder-innovations)[[2]](https://exa.ai/websets/directory/shoulder-innovations-executives). In 2013, he co-founded Genesis Innovation Group, an early-stage advisory firm for medical device technology that operates multiple subsidiaries including Genesis Software Innovations and Revelation Medical Devices[[1]](https://www.medsider.com/interviews/rob-ball-shoulder-innovations). At Shoulder Innovations, Ball has led the company's development and commercialization of proprietary InSet® glenoid fixation technology, addressing critical challenges in shoulder arthroplasty and establishing the company's position as a market leader[[1]](https://www.medsider.com/interviews/rob-ball-shoulder-innovations)[[2]](https://exa.ai/websets/directory/shoulder-innovations-executives). Under his leadership, Shoulder Innovations successfully completed its initial public offering on the New York Stock Exchange in 2026[[3]](https://www.youtube.com/watch?v=bZ3zVac61L8)[[4]](https://shoulderinnovations.com/rob-ball-interviewed-on-nyse-tv/).

View full insider profile →

Trade Price

$15.18

Quantity

2,200

Total Value

$33,392.00

Shares Owned

278,866

Trade Date

Friday, March 13, 2026

4 days ago

SEC Filing Date

Tuesday, March 17, 2026

Filed 4 days after trade

NONENONE

About Shoulder Innovations, Inc.

Company Overview

No company information available
View news mentioning SI

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/4868951

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime